BRENTUXIMAB VEDOTIN MAY CUT RADIATION USE IN PEDIATRIC HODGKIN LYMPHOMA

被引：0
|
作者：
不详
机构：
来源：
CANCER DISCOVERY | 2021年 / 11卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1318 / 1318
页数：1
相关论文
共 50 条
  • [1] BRENTUXIMAB VEDOTIN IS EFFECTIVE IN HODGKIN LYMPHOMA
    不详
    CANCER DISCOVERY, 2012, 2 (05) : 385 - 385
  • [2] Brentuximab vedotin in Hodgkin's lymphoma
    Pro, Barbara
    Perini, Guilherme Fleury
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2012, 12 (10) : 1415 - 1421
  • [3] Brentuximab vedotin and transplantation in Hodgkin Lymphoma
    Castagna, Luca
    Sarina, Barbara
    Bramanti, Stefania
    Calabretta, Eleonora
    Mariotti, Jacopo
    Morabito, Lucio
    DRUGS AND CELL THERAPIES IN HEMATOLOGY, 2015, 3 (04): : 218 - 225
  • [4] Brentuximab vedotin use in a jaundiced case with resistant Hodgkin lymphoma
    Paydas, Semra
    Ogul, Ali
    Irili, Cem
    Gokcay, Serkan
    ANNALS OF HEMATOLOGY, 2016, 95 (01) : 145 - 146
  • [5] Brentuximab vedotin use in a jaundiced case with resistant Hodgkin lymphoma
    Semra Paydas
    Ali Ogul
    Cem Irili
    Serkan Gokcay
    Annals of Hematology, 2016, 95 : 145 - 146
  • [6] Brentuximab Vedotin in Advanced Hodgkin's Lymphoma
    Haslam, Alyson
    Prasad, Vinay
    NEW ENGLAND JOURNAL OF MEDICINE, 2022, 387 (16): : 1527 - 1527
  • [7] Brentuximab Vedotin in Children with Hodgkin's Lymphoma
    Kazantsev, I.
    Kozlov, A.
    Iukhta, T.
    Gevorgian, A.
    Tolkunova, P.
    Tsvetkova, L.
    Morozova, E.
    Lepik, K.
    Kulagin, A.
    Mikhailova, N.
    Zubarovskaya, L.
    PEDIATRIC BLOOD & CANCER, 2021, 68 : S202 - S202
  • [8] Desensitization of Brentuximab Vedotin in a Patient with Hodgkin Lymphoma
    Khalid, Sidra
    Khalid, Aariez
    Clark, Bernadette A.
    Daw, Hamed
    CUREUS, 2018, 10 (07):
  • [9] Brentuximab vedotin for the treatment of Hodgkin's lymphoma
    Anh Pham
    Chen, Robert
    EXPERT REVIEW OF HEMATOLOGY, 2015, 8 (04) : 403 - 412
  • [10] Brentuximab vedotin for advanced Hodgkin's lymphoma
    Fanale, Michelle A.
    LANCET ONCOLOGY, 2017, 18 (12): : 1566 - 1568
12345